These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18709384)

  • 21. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.
    Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.
    Salinas-Alamán A; Zarranz-Ventura J; Caire González-Jauregui JM; Sádaba-Echarri LM; Barrio-Barrio J; García-Layana A
    Eur J Ophthalmol; 2011; 21(4):434-9. PubMed ID: 21140369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F; Ozmert E; Parmak N; Celik S
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitrectomy alone versus vitrectomy with simultaneous intravitreal injection of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Uemura A; Yamamoto S; Sato E; Sugawara T; Mitamura Y; Mizunoya S
    Ophthalmic Surg Lasers Imaging; 2009; 40(1):6-12. PubMed ID: 19205489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.
    Cekiç O; Chang S; Tseng JJ; Barile GR; Del Priore LV; Weissman H; Schiff WM; Ober MD
    Retina; 2005; 25(7):851-5. PubMed ID: 16205563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of injection of intravitreal drugs with standard care in macular edema secondary to branch retinal vein occlusion.
    Lee K; Jung H; Sohn J
    Korean J Ophthalmol; 2014 Feb; 28(1):19-25. PubMed ID: 24505197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab.
    Yoo SG; Kim JH; Lee TG; Kim CG; Kim JW
    Indian J Ophthalmol; 2015 Jan; 63(1):25-9. PubMed ID: 25686058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
    Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G
    Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion.
    Tsujikawa A; Fujihara M; Iwawaki T; Yamamoto K; Kurimoto Y
    Retina; 2005; 25(7):861-7. PubMed ID: 16205565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.
    Senturk F; Ozdemir H; Karacorlu M; Karacorlu SA; Uysal O
    Retina; 2010 Sep; 30(8):1254-61. PubMed ID: 20827142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion.
    Kawaji T; Takano A; Inomata Y; Sagara N; Iwao K; Inatani M; Fukushima M; Tanihara H
    Br J Ophthalmol; 2008 Jan; 92(1):81-3. PubMed ID: 17965103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment.
    Parodi MB; Iacono P; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1647-51. PubMed ID: 25382074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion.
    Ozkiris A; Evereklioglu C; Erkiliç K; Ilhan O
    Eur J Ophthalmol; 2005; 15(1):96-101. PubMed ID: 15751246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.
    Iturralde D; Spaide RF; Meyerle CB; Klancnik JM; Yannuzzi LA; Fisher YL; Sorenson J; Slakter JS; Freund KB; Cooney M; Fine HF
    Retina; 2006 Mar; 26(3):279-84. PubMed ID: 16508427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early versus late intravitreal triamcinolone acetonide for macular edema associated with branch retinal vein occlusion.
    Oh JY; Seo JH; Ahn JK; Heo JW; Chung H
    Korean J Ophthalmol; 2007 Mar; 21(1):18-20. PubMed ID: 17460427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision.
    Lim JW; Na KI
    Indian J Ophthalmol; 2011; 59(2):93-6. PubMed ID: 21350277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study.
    Hou J; Tao Y; Jiang YR; Li XX; Gao L
    Chin Med J (Engl); 2009 Nov; 122(22):2695-9. PubMed ID: 19951598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal triamcinolone for refractory diabetic macular edema.
    Martidis A; Duker JS; Greenberg PB; Rogers AH; Puliafito CA; Reichel E; Baumal C
    Ophthalmology; 2002 May; 109(5):920-7. PubMed ID: 11986098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.